Suchergebnisse

1. Tesch F, Ehm F, Vivirito A, Wende D, Batram M, Loser F, Menzer S, Jacob J, Roessler M, Seifert M, Kind B, König C, Schulte C, Buschmann T, Hertle D, Ballesteros P, Baßler S, Bertele B, Bitterer T, Riederer C, Sobik F, Reitzle L, Scheidt-Nave C, Schmitt J (2023): Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study.
   Clin Rheumatol.: doi: 10.1007/s10067-023-06670-0. mehr

2. Du Y, Baumert J, Paprott R, Färber F, Nübel J, Hermanns N, Heidemann C, Scheidt-Nave C (2023): Diabetes-related distress and associated factors among adults with diabetes in Germany: Results of the nationwide study “Disease knowledge and information needs - Diabetes mellitus 2017”.
   J Psychosom Res. 164: 111073. doi: 10.1016/j.jpsychores.2022.111073. mehr

3. Schmidt D, Kollan C, Stoll M (2023): Wie steht es um die Long Acting-Therapie in Deutschland? – Zahlen zu Verordnungen von Cabotegravir in Deutschland.
   Eid Bull (25): 3-10. doi: 10.25646/11534. mehr

4. Kolb JJ, Radin JM, Quer G, Rose AH, Pandit JA, Wiedermann M (2023): Prevalence of Positive COVID-19 Test Results Collected by Digital Self-report in the US and Germany.
   JAMA Netw Open 6 (1): 4. doi: 10.1001/jamanetworkopen.2022.53800. mehr

5. Gao L, Lam KH, Liu S, Przykopanski A, Lübke J, Qi R, Krüger M, Nowakowska MB, Selby K, Douillard FP, Dorner MB, Dorner BG, Perry K, Lindström M, Rummel A, Jin R (2023): Crystal structures of OrfX1, OrfX2, and the OrfX1-OrfX3 complex from the orfX gene cluster of botulinum neurotoxin E1.
   FEBS Lett.: doi: 10.1002/1873-3468.14576. mehr

6. Hommes F, Krings A, Dörre A, Neumeier E, Schäffer D, Zimmermann R (2023): International harm reduction indicators are still not reached: results from a repeated cross-sectional study on drug paraphernalia distribution in Germany, 2021.
   Harm Reduct J 20 (137): doi: 10.1186/s12954-023-00870-2. mehr

7. Charalampous P, Haagsma JA, Jakobsen LS, Gorasso V, Noguer I, Padron-Monedero A, Sarmiento R, Santos JV, McDonald SA, Plass D, Wyper GMA, Assunção R, von der Lippe E, Ádám B, AlKerwi A, Arabloo J, Baltazar AL, Bikbov B, Borrell-Pages M, Brus I, Burazeri G, Chaintoutis SC, Chen-Xu J, Chkhaberidze N, Cilovic-Lagarija S, Corso B, Cuschieri S, Di Bari C, Dopelt K, Economou M, Emeto TI, Fantke P, Fischer F, Freitas A, García-González JM, Gazzelloni F, Gissler M, Gkitakou A, Gulmez H, Gunes S, Haller S, Haneef R, Hincapié CA. Hynds P, Idavain J, Ilic M, Ilic I, Isola G, Kabir Z, Kamusheva M, Kolkhir P, Konar NM, Kostoulas P, Kulimbet M, La Vecchia C, Lauriola P, Levi M, Majer M, Mechili EA, Monasta L, Mondello S, Muñoz Laguna J, Nena E, Ng ES, Nguewa P, Niranjan V, Nola IA, O’Caoimh R, Obradović M, Pallari E, Peyroteo M, Pinheiro V, Pranjic N, Reina Ortiz M, Riva S, Santoso CMA, Santric Milicevic M, Schmitt T, Speybroeck N, Sprügel M, Steiropoulos P, Stevanovic A, Thygesen LC, Tozija F, Unim B, Bektaş Uysal H, Varga O, Vasic M, Vieira RJ, Yigit V, Devleesschauwer B, Pires SM (2023): Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices.
   Epidemiol Infect. (151): e19. doi: 10.1017/S0950268823000031. mehr

8. Steinbeis F, Thibeault C, Steinbrecher S, Ahlgrimm Y, Haack IA, August D, Balzuweit B, Bellinghausen C, Berger S, Chaplinskaya-Sobol I, Cornely O, Doeblin P, Endres M, Fink C, Finke C, Frank S, Hanß S, Hartung T, Hellmuth JC, Herold S, Heuschmann P, Heyckendorf J, Heyder R, Hippenstiel S, Hoffmann W, Kelle SU, Knape P, Koehler P, Kretzler L, Leistner DM, Lienau J, Lorbeer R, Lorenz-Depiereux B, Lüttke CD, Mai K, Merle U, Meyer-Arndt LA, Miljukov O, Muenchhoff M, Müller-Plathe M, Neuhann J, Neuhauser H, Nieters A, Otte C, Pape D, Pinto RM, Pley C, Pudszuhn A, Reuken P, Rieg S, Ritter P, Rohde G, Rönnefarth M, Ruzicka M, Schaller J, Schmidt A, Schmidt S, Schwachmeyer V, Schwanitz G, Seeger W, Stahl D, Stobäus N, Stubbe HC, Suttorp N, Temmesfeld B, Thun S, Triller P, Trinkmann F, Vadasz I, Valentin H, Vehreschild M, von Kalle C, von Lilienfeld-Toal M, Weber J, Welte T, Wildberg C, Wizimirski R, Zvork S, Sander LE, Vehreschild J, Zoller T, Kurth F, Witzenrath M (2023): Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP).
   Infection.: doi: 10.1007/s15010-023-02057-0. mehr

9. Loenenbach A, Buda S, Faensen D, Haas W, Lehfeld A-S, Prahm K, Prohl M, Spindler S, Wesseler D, Buchholz U (2023): COVID-19-Raten unter Kindern und Erwachsenen — Ergebnisse aus dem bevölkerungsbasierten Online-Portal GrippeWeb.
   Epid Bull: 3-13. doi: 10.25646/11292. mehr

10. Kröger S (2023): Welttuberkulosetag 2023: Yes! We Can End TB!
    Epid Bull 11: 3-5. doi 10.25646/11208. mehr

11. Reiß F, Kaman A, Napp AK, Devine J, Li LY, Strelow L, Erhart M, Hölling H, Schlack R, Ravens-Sieberer U (2023): Epidemiologie seelischen Wohlbefindens von Kindern und Jugendlichen in Deutschland. Ergebnisse aus 3 Studien vor und während der COVID-19-Pandemie. [Epidemiology of mental well-being in childhood and adolescence. Results from three epidemiological studies before and during the COVID-19 pandemic].
    Bundesgesundheitsblatt. 66 (7): 727–735. doi: 10.1007/s00103-023-03720-5. mehr

12. Geurts B, Weishaar H, Mari Saez A, Cristea F, Rocha C, Aminu K, Tan MMJ, Salim Camara B, Barry L, Thea P, Boucsein J, Bahr T, Al-Awlaqi S, Pozo-Martin F, Boklage E, Delamou A, Jegede AS, Legido-Quigley H , El Bcheraoui C (2023): Communicating risk during early phases of COVID-19: Comparing governing structures for emergency risk communication across four contexts
    Front. Public Health 11: doi: 10.3389/fpubh.2023.1038989. mehr

13. Bartig S, Beese F, Wachtler B, Grabka MM, Mercuri E, Schmid L, Schmid-Küpke NK, Schranz M, Goßner L, Niehues W, Zinn S, Poethko-Müller C, Schaade L, Hövener C, Gößwald A, Hoebel J (2023): Socioeconomic Differences in SARS-CoV-2 Infection and Vaccination in Germany: A Seroepidemiological Study After One Year of COVID-19 Vaccination Campaign
    International Journal of Public Health 68: doi: 10.3389/ijph.2023.1606152. mehr

14. Bunse T, Koerber N, Wintersteller H, Schneider J, Graf A, Radonic A, Thuermer A, von Kleist M, Blum H, Spinner CD, Bauer T, Knolle PA, Protzer U, Schulte EC (2023): T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual.
    Microorganisms. 11 (6): 1562. doi: 10.3390/microorganisms11061562. mehr

15. Cohrdes C, Pryss R, Baumeister H, Eicher S, Knoll N, Hölling H (2023): Support- and meaning-focused coping as key factors for maintaining adult quality of life during the COVID-19 pandemic in Germany.
    Front. Public Health 11: doi: 10.3389/fpubh.2023.1196404. mehr

16. Mansour Ghanaie R, Boone I, Shamshiri AR, Karimi A, Amirali A, Marhamati N, Rostami MH, Pashaei N, Janbazi S, Azimi L, Khodaei H, Fallah F, Eckmanns T, Jansen A , Baradaran HR, Ourimi MM, Maham S, Elikaei A, Alebouyeh M (2023): Seroepidemiological and Molecular Survey for the Detection of SARS-CoV-2 Infection among Children in Iran, September 2020 to June 2021: 1-Year Cross-Sectional Study.
    Microorganisms. 11 (7): 1-12 doi: 10.3390/microorganisms11071672. mehr

17. Klamser PP, Andrea Vd, Lauro FD, Zachariae A, Bontorin S, Nardo Ad, Hall M, Maier BF, Ferretti L, Brockmann D, Domenico MD (2023): Enhancing global preparedness during an ongoing pandemic from partial and noisy data
    PNAS Nexus: doi: 10.1093/pnasnexus/pgad192. mehr

18. Grundeis F, Ansems K, Dahms K, Thieme V, Metzendorf M, Skoetz N, Benstoem C, Mikolajewska A, Griesel M, Fichtner F, Stegemann M (2023): Remdesivir for the treatment of COVID‐19
    Cochranelibrary: 123. doi: 10.1002/14651858.CD014962.pub2/full. mehr

19. Thom J, Walther L, Eicher S, Hölling H, Junker S, Peitz D, Wilhelm J, Mauz E (2023): Mental Health Surveillance am Robert Koch-Institut – Strategien zur Beobachtung der psychischen Gesundheit der Bevölkerung [Mental health surveillance at the Robert Koch Institute - strategies for monitoring the mental health of the population].
    Bundesgesundheitsbl: Published online: 27 February 2023. doi: 10.1007/s00103-023-03678-4. mehr

20. Marcus U, Schmidt D, Friebe M, Kollan C, Gunsenheimer-Bartmeyer B, Bremer V (2023): Gemeldete HIV-Erstdiagnosen 2021 – 2022.
    Epid Bull. (35): 3-18. doi: 10.25646/11678. mehr

Resultate 61 bis 80 von insgesamt 12.037